The U.S. edged closer to half a million deaths from the coronavirus-borne illness COVID-19 on Monday, as experts braced for a Food and Drug Administration advisory committee meeting later this week to review Johnson & Johnson’s vaccine candidate.
The J&J vaccine would be a game changer in the vaccine program if it wins authorization, as it’s a single-dose regimen and does not have the refrigeration requirements of the existing authorized jabs, all of which require two doses weeks apart.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,